Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...
Google just dropped 4 new Gemini 2.0-series models, with some designed for coding performance and complex prompts and the ...
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...
If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...
Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...
Vertex has built an empire in cystic fibrosis (CF) treatment, recently crowning its dominance with Alyftrek's approval last month. This latest CF drug adds even more firepower to a franchise ...
Google TV is one of the best streaming platforms out there, running on everything from smart TVs to the best streaming devices, and Google TV Streamer. This web-connected OS is built to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback